These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210 [TBL] [Abstract][Full Text] [Related]
4. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I. von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431 [TBL] [Abstract][Full Text] [Related]
5. Intracellular expression of MICA in activated CD4 T lymphocytes and protection from NK cell-mediated MICA-dependent cytotoxicity. Molinero LL; Domaica CI; Fuertes MB; Girart MV; Rossi LE; Zwirner NW Hum Immunol; 2006 Mar; 67(3):170-82. PubMed ID: 16698439 [TBL] [Abstract][Full Text] [Related]
6. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Sáez-Borderías A; Gumá M; Angulo A; Bellosillo B; Pende D; López-Botet M Eur J Immunol; 2006 Dec; 36(12):3198-206. PubMed ID: 17109473 [TBL] [Abstract][Full Text] [Related]
7. (5R)-5-hydroxytriptolide inhibits IFN-gamma-related signaling. Zhou R; Wang JX; Tang W; He PL; Yang YF; Li YC; Li XY; Zuo JP Acta Pharmacol Sin; 2006 Dec; 27(12):1616-21. PubMed ID: 17112417 [TBL] [Abstract][Full Text] [Related]
8. Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor. Zhang T; Barber A; Sentman CL Cancer Res; 2006 Jun; 66(11):5927-33. PubMed ID: 16740733 [TBL] [Abstract][Full Text] [Related]
9. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765 [TBL] [Abstract][Full Text] [Related]
10. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells. Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290 [TBL] [Abstract][Full Text] [Related]
11. Human anti-porcine T cell response: blocking with anti-class I antibody leads to hyporesponsiveness and a switch in cytokine production. DerSimonian H; Pan L; Yatko C; Rodrigue-Way A; Johnson E; Edge AS J Immunol; 1999 Jun; 162(12):6993-7001. PubMed ID: 10358140 [TBL] [Abstract][Full Text] [Related]
12. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis. Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357 [TBL] [Abstract][Full Text] [Related]
13. Regulation of cutaneous malignancy by gammadelta T cells. Girardi M; Oppenheim DE; Steele CR; Lewis JM; Glusac E; Filler R; Hobby P; Sutton B; Tigelaar RE; Hayday AC Science; 2001 Oct; 294(5542):605-9. PubMed ID: 11567106 [TBL] [Abstract][Full Text] [Related]
14. Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28. Molinero LL; Fuertes MB; Rabinovich GA; Fainboim L; Zwirner NW J Leukoc Biol; 2002 May; 71(5):791-7. PubMed ID: 11994503 [TBL] [Abstract][Full Text] [Related]
15. [Immunobiological characterization of murine LB leukemia and the LBC cell line]. Hajos SE; Mongini C; Waldner C; Sánchez Lockhart M; Gravisaco MJ; Roig I; Fernańdez T; Alvarez E Medicina (B Aires); 1996; 56 Suppl 1():45-56. PubMed ID: 9224974 [TBL] [Abstract][Full Text] [Related]
16. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus. Yang D; Wang H; Ni B; He Y; Li J; Tang Y; Fu X; Wang Q; Xu G; Li K; Yang Z; Wu Y Mol Immunol; 2009 Apr; 46(7):1432-42. PubMed ID: 19200602 [TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy. Choi BK; Kim YH; Kang WJ; Lee SK; Kim KH; Shin SM; Yokoyama WM; Kim TY; Kwon BS Cancer Res; 2007 Sep; 67(18):8891-9. PubMed ID: 17875731 [TBL] [Abstract][Full Text] [Related]
20. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites? Zhang S; Hüe S; Sène D; Penfornis A; Bresson-Hadni S; Kantelip B; Caillat-Zucman S; Vuitton DA J Infect Dis; 2008 May; 197(9):1341-9. PubMed ID: 18422447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]